These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 31114158)
1. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo. Chen S; Zhang Z; Zhang J Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158 [No Abstract] [Full Text] [Related]
2. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro. Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123 [TBL] [Abstract][Full Text] [Related]
3. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo. Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522 [TBL] [Abstract][Full Text] [Related]
4. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of paclitaxel in non-small cell lung cancer cells via Nrf2 inhibition. Chen X; Wu Q; Chen Y; Zhang J; Li H; Yang Z; Yang Y; Deng Y; Zhang L; Liu B Br J Pharmacol; 2019 Jun; 176(12):2079-2094. PubMed ID: 30825187 [TBL] [Abstract][Full Text] [Related]
5. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer. Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279 [TBL] [Abstract][Full Text] [Related]
6. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells. Yuan H; Sun B; Gao F; Lan M Pharm Biol; 2016 Nov; 54(11):2629-2635. PubMed ID: 27159496 [TBL] [Abstract][Full Text] [Related]
7. Functionalization of Silver Nanoparticles Loaded with Paclitaxel-induced A549 Cells Apoptosis Through ROS-Mediated Signaling Pathways. Zou J; Zhu B; Li Y Curr Top Med Chem; 2020; 20(2):89-98. PubMed ID: 31648639 [TBL] [Abstract][Full Text] [Related]
8. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin. Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493 [TBL] [Abstract][Full Text] [Related]
10. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway. Su J; Yan Y; Qu J; Xue X; Liu Z; Cai H Oncol Rep; 2017 Mar; 37(3):1565-1572. PubMed ID: 28184934 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells. Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431 [TBL] [Abstract][Full Text] [Related]
12. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth. Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729 [TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway. Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model. Marostica LL; de Barros ALB; Oliveira J; Salgado BS; Cassali GD; Leite EA; Cardoso VN; Lang KL; Caro MSB; Durán FJ; Schenkel EP; de Oliveira MC; Simões CMO Toxicol Appl Pharmacol; 2017 Aug; 329():272-281. PubMed ID: 28610991 [TBL] [Abstract][Full Text] [Related]
15. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Zhu K; Fang W; Chen Y; Lin S; Chen X Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway. Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165 [TBL] [Abstract][Full Text] [Related]
17. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study. Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554 [TBL] [Abstract][Full Text] [Related]
18. Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro. Liu Y; Xia H; Wang Y; Han W; Qin J; Gao W; Qu X; Wang X Thorac Cancer; 2021 Nov; 12(22):3053-3061. PubMed ID: 34617400 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer. Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]